Head Coil MarketSize, Share & Industry Analysis, 2026-2034By TypeBy ApplicationBy Coil DesignBy End UserBy Field Strength

A head coil is the dedicated radiofrequency receiver hardware fitted around a patient's skull during magnetic resonance imaging, used to capture the signal that forms neurological, sinus, and related diagnostic scans. It comes in rigid cage designs and newer flexible, multi-channel phased-array formats that conform closer to the head for improved signal pickup and patient comfort. Buyers are hospitals, diagnostic imaging centers, academic and research institutes, and veterinary imaging practices that operate MRI scanners and need coils matched to their scanner's field strength and channel architecture.

The global head coil market is valued at USD 1850 million in 2025 and is set to reach USD 3650 million by 2034, a compound annual growth rate of 7.74% across the 2026-2034 forecast period. The study tracks the market across USD 1220 million in 2020, USD 1660 million in 2024, USD 2010 million in 2026 and USD 2750 million in 2030.

45% of 2025 revenue sits in 12-32 Channels, worth USD 832.5 million and rising to USD 1460 million at 40% by 2034, the largest type line in both years. Growth is fastest in More Than 32 Channels at 13.92% and slowest in 4-12 Channels at 1.65%. More Than 32 Channels take share over the period; 4-12 Channels and 12-32 Channels give it up while still growing in absolute terms.

Cut by application, the largest line is For Humans: 93% of 2025 revenue, worth USD 1720.5 million, and 91.5% at USD 3339.8 million by 2034. For Animals grows faster at 11.04% against 7.65%, moving from 5% of revenue to 6.5% by 2034. Both this axis and the type one divide the same revenue, which is why they are alternative views rather than components.

The regional order runs from North America at 33% of 2025 revenue down to Middle East and Africa at 5%. North America is worth USD 610.5 million in 2025 and USD 1095 million in 2034; Asia Pacific, second at 30%, moves from USD 555 million to USD 1277.5 million. Asia Pacific, Latin America and Middle East and Africa gain share across the period, so growth is not distributed evenly between regions.

Behind these figures sit five regions, three type lines and five segmentation axes, each reported for every year from 2020 to 2034. The headline 2025 value is arrived at by triangulating published aggregates against category proxies, not by an independent count, and the same applies to the segment, regional and country breakdowns drawn from it.

• A forecast-period rate of 7.74% takes the market from USD 1850 million in 2025 to USD 3650 million in 2034, against 8.68% recorded over the 2020-2025 historical period.
• The largest line by type is 12-32 Channels, worth USD 832.5 million and 45% of revenue in 2025, rising to USD 1460 million and 40% by 2034.
• At 13.92%, More Than 32 Channels grows faster than any other type line, moving from USD 462.5 million and 25% of revenue in 2025 to USD 1533 million and 42% in 2034.
• The bull case puts 2034 revenue at USD 4015 million and the bear case at USD 3285 million, either side of the USD 3650 million base case, each with its own stated assumption in the full report.
• The largest region is North America, generating USD 610.5 million in 2025 (33% of the global total) and USD 1095 million by 2034, ahead of Asia Pacific at 30%.
• The United States accounts for 86% of North America in the base year, worth USD 525 million in 2025 and reaching USD 941.7 million by 2034, the worked country example carried through that region's chapters.
• The study covers 2020 through 2034 with 2025 as the base year, reporting five regions and five segmentation axes separately, with revenue, share and a growth rate for every line in each year.

Read across the forecast period, the global head coil market shows movement in three places: type composition, regional weight, and the 7.74% rate applied to the whole.

None of them reverses the market's direction. Every line and every region grows in absolute terms across the period; what changes is which of them captures the revenue added.

Composition shifts on the type axis. 13.92% against 1.65%: that gap, between More Than 32 Channels and 4-12 Channels, is the largest on the type axis. Shares follow: 25% to 42% for More Than 32 Channels, 30% to 18% for 4-12 Channels. The revenue figures behind that are USD 462.5 million to USD 1533 million and USD 555 million to USD 657 million. Both expand; where a supplier sits on the axis still decides whether it tracks the market.

Asia Pacific, Latin America and Middle East and Africa gain regional share. Asia Pacific moves from 30% of revenue in 2025 to 35% in 2034, worth USD 555 million rising to USD 1277.5 million; Latin America moves from 5% of revenue in 2025 to 5.5% in 2034, worth USD 92.5 million rising to USD 200.8 million; Middle East and Africa moves from 5% of revenue in 2025 to 5.5% in 2034, worth USD 92.5 million rising to USD 200.8 million. The remaining regions grow in absolute terms while giving up share: North America at 33% moving to 30%, Europe at 27% moving to 24%. Growth is therefore not something a participant inherits from the market; it depends on which regions its revenue is weighted toward.

The series never breaks trajectory. Year by year the total runs USD 1220 million in 2020, USD 1660 million in 2024, USD 1850 million in 2025, USD 2010 million in 2026, USD 2750 million in 2030 and USD 3650 million in 2034. No year breaks the trajectory, and the 7.74% forecast rate compares with 8.68% recorded over 2020-2025, a continuation rather than an inflection. A plan built on this market is therefore a plan about capturing a share of steady expansion, which is decided on the type and regional axes, not by the headline rate.

More Than 32 Channels adds the most incremental growth

Three sources account for the growth to 2034: 7.74% compounding across the base, share moving toward the faster type lines, and above-market expansion in the leading regions.

Downside case: USD 3285 million rather than USD 3650 million by 2034

Upside case: USD 4015 million by 2034

One type line carries the market

North America holds 33% of the global head coil market in 2025, worth USD 610.5 million and reaches USD 1095 million by 2034. By revenue it sits first across the study, and the ranking does not change between 2025 and 2034.

Its share moves to 30% by 2034, and the region keeps growing in absolute terms while others expand faster, a change in relative weight, not a decline in demand.

12-32 Channels leads here as it does globally, at 45% of 2025 revenue, and More Than 32 Channels again grows fastest at 13.92%. Revenue for North America is broken out by every segmentation axis and by country in the full report.

86% of North America's base-year revenue comes from the United States; USD 525 million, rising to USD 941.7 million by 2034. 86% of the region in 2025 means the regional figures are, in practice, a view of this market with others attached. The region itself runs USD 610.5 million to USD 1095 million over the same period, and this is the market carrying the country-level detail in the full report.

Composition here matches the global split: the largest line is 12-32 Channels at 45% of 2025 revenue, easing to 40% by 2034, and the fastest is More Than 32 Channels at 13.92%, from 25% to 42%. Because the country carries 86% of North America, a movement in its own mix shows up in the regional totals rather than being averaged away by neighbouring markets. The full report reports the United States by type separately.

In the United States, head coils used in magnetic resonance imaging fall under the Food and Drug Administration's medical device framework, typically routed through its premarket notification pathway rather than the more stringent premarket approval process. Manufacturers must demonstrate substantial equivalence to a legally marketed predicate device, maintain design controls, and conform to the agency's quality system requirements, which mirror the internationally recognized quality management standard for medical device manufacturing. Facilities are subject to registration, listing, and periodic inspection, while labelling must clearly state intended use, compatibility, and safety warnings for magnetic resonance environments. Post-market obligations include complaint handling, adverse event reporting, and corrective action tracking to sustain continued market access.

GE, MR Instruments, Philips, Hitachi, Shimadsu, Toshiba, LMT Medical Systems, Neusoft, Siemens Healthineers, Esaote, Rapid Biomedical, Hallmarq Veterinary, QED (Quality Electrodynamics) and NORAS MRI products are the suppliers covered in the United States. Two different problems sit on the same axis: holding 12-32 Channels at 45% of 2025 revenue, and taking More Than 32 Channels while it grows at 13.92%. Per-company positioning and share at country level are in the full report only.

Canada is sized at USD 85.5 million in 2025, rising to USD 153.3 million by 2034; 4.6% of global revenue and 14% of North America. It is reported separately from the United States across every segmentation axis in the full report.

In Europe, 27% of global revenue puts 2025 at USD 499.5 million rising to USD 876 million in 2034. That makes it the third-largest region covered, in 2025 and again in 2034.

24% of global revenue sits here in 2034, below the 2025 level, while nothing contracts here; other regions simply grow faster, which shows up as relative weight rather than as falling revenue.

Segment composition follows the global pattern: 12-32 Channels largest at 45% of 2025 revenue, More Than 32 Channels fastest at 13.92%. The full report breaks Europe out along every axis and by country.

32% of Europe's base-year revenue comes from Germany; USD 159.8 million, rising to USD 280.3 million by 2034. 32% of the region in the base year makes it the largest market here without making it the region. Against regional totals of USD 499.5 million in 2025 and USD 876 million in 2034, it is the country the full report breaks out in detail.

Demand in Germany follows the type mix reported at global level: 12-32 Channels is the largest line at 45% of 2025 revenue, moving to 40% by 2034, while More Than 32 Channels grows fastest at 13.92% and takes its share from 25% to 42%. Since 32% of Europe's revenue is generated here, the regional numbers inherit this market's mix rather than smoothing it out. The full report reports Germany by type separately.

In Germany, head coils are regulated as medical devices under the European Union's Medical Device Regulation, enforced domestically through the national medical devices act and overseen by the Federal Institute for Drugs and Medical Devices alongside designated Notified Bodies. Manufacturers must classify the coil according to its intended use and risk profile, compile technical documentation demonstrating conformity with harmonized standards, and undergo a Notified Body conformity assessment before affixing the CE mark. A quality management system aligned with the recognized medical device standard is expected, along with a designated person responsible for regulatory compliance. Post-market surveillance, vigilance reporting, and traceability through unique device identification obligations continue once the coil is placed on the market.

The suppliers tracked in this study (GE, MR Instruments, Philips, Hitachi, Shimadsu, Toshiba, LMT Medical Systems, Neusoft, Siemens Healthineers, Esaote, Rapid Biomedical, Hallmarq Veterinary, QED (Quality Electrodynamics) and NORAS MRI products) compete in Germany across the type lines above. Two different problems sit on the same axis: holding 12-32 Channels at 45% of 2025 revenue, and taking More Than 32 Channels while it grows at 13.92%.

The United Kingdom is sized at USD 109.9 million in 2025, rising to USD 192.7 million by 2034; 5.9% of global revenue and 22% of Europe. It is reported separately from Germany across every segmentation axis in the full report.

France is sized at USD 89.9 million in 2025, rising to USD 157.7 million by 2034; 4.9% of global revenue and 18% of Europe. It is reported separately from Germany across every segmentation axis in the full report.

In Asia Pacific, 30% of global revenue puts 2025 at USD 555 million rising to USD 1277.5 million in 2034. It is a leading region on this axis, second by revenue throughout the period.

By 2034 the share has moved up to 35%, on growth above the market's own 7.74%, and with a bigger contribution to the revenue added over the period than the base-year figure suggests.

12-32 Channels leads here as it does globally, at 45% of 2025 revenue, and More Than 32 Channels again grows fastest at 13.92%. Per-axis and per-country detail for Asia Pacific sits in the full report.

The largest single market in Asia Pacific is Japan, at USD 166.5 million in 2025 and USD 332.2 million in 2034. At 30% of the region in 2025 it leads, but a majority of Asia Pacific's revenue is generated in other markets. Against regional totals of USD 555 million in 2025 and USD 1277.5 million in 2034, it is the country the full report breaks out in detail.

Composition here matches the global split: the largest line is 12-32 Channels at 45% of 2025 revenue, easing to 40% by 2034, and the fastest is More Than 32 Channels at 13.92%, from 25% to 42%. Its 30% weight in Asia Pacific means those movements carry straight into the regional totals. Japan carries its own type breakdown in the full report.

In Japan, head coils intended for magnetic resonance imaging are regulated under the Pharmaceuticals and Medical Devices Act, administered by the Ministry of Health, Labour and Welfare with review support from the Pharmaceuticals and Medical Devices Agency. Depending on classification, a supplier must obtain either a certification through a registered certification body or direct ministerial approval, supported by evidence of conformity with recognized international and domestic technical standards. Manufacturing and quality control activities must satisfy the ministerial ordinance governing quality management systems for medical devices, and a marketing authorization holder based in Japan is required to maintain regulatory accountability. Labelling in Japanese, post-market safety monitoring, and adverse event reporting obligations apply throughout the product's commercial life.

The suppliers tracked in this study (GE, MR Instruments, Philips, Hitachi, Shimadsu, Toshiba, LMT Medical Systems, Neusoft, Siemens Healthineers, Esaote, Rapid Biomedical, Hallmarq Veterinary, QED (Quality Electrodynamics) and NORAS MRI products) compete in Japan across the type lines above. The commercially relevant division is 45% of 2025 revenue in 12-32 Channels, where the volume is, against 13.92% growth in More Than 32 Channels, where share moves.

Within Asia Pacific, China accounts for 28% of regional revenue and 8.4% of the global total, worth USD 155.4 million in 2025 and USD 408.8 million by 2034.

Within Asia Pacific, South Korea accounts for 12% of regional revenue and 3.6% of the global total, worth USD 66.6 million in 2025 and USD 153.3 million by 2034.

5% of the global head coil market sits in Latin America in 2025, worth USD 92.5 million with USD 200.8 million projected for 2034. It is a marginal region on this axis, fourth by revenue throughout the period.

5.5% of global revenue sits here by 2034, up from the 2025 level, at a pace above the 7.74% global rate, which is what makes this region worth reading separately rather than scaling from the total.

The type mix reported at global level applies here, with 12-32 Channels the largest line at 45% of 2025 revenue and More Than 32 Channels the fastest-growing at 13.92%. Revenue for Latin America is broken out by every segmentation axis and by country in the full report.

55% of Latin America's base-year revenue comes from Brazil; USD 50.9 million, rising to USD 110.4 million by 2034. It accounts for 55% of regional revenue in the base year, the largest single share without dominating the region outright. Set against USD 92.5 million and USD 200.8 million for the region, it is why this market rather than a smaller one is the one reported in full.

Brazil buys along the same lines as the market globally; 12-32 Channels first at 45% of 2025 revenue and 40% in 2034, More Than 32 Channels fastest at 13.92% on a share moving from 25% to 42%. With 55% of Latin America concentrated here, a change in this country's mix is visible in the regional figures instead of being diluted by its neighbours. Revenue by type for Brazil is reported separately in the full report.

In Brazil, head coils fall under the health surveillance authority ANVISA's medical device regulatory regime, which classifies products by risk and mandates registration before commercialization. A local manufacturer or an in-country registration holder must submit technical documentation demonstrating compliance with applicable national and internationally harmonized standards, alongside evidence of a certified quality management system, typically verified through good manufacturing practice inspection. Portuguese-language labelling and instructions for use are mandatory, covering intended use, compatibility, and safety precautions. Once registered, the product remains subject to ongoing pharmacovigilance-style adverse event reporting, periodic registration renewal, and inspection to confirm continued conformity with the country's technical and sanitary requirements.

The suppliers tracked in this study (GE, MR Instruments, Philips, Hitachi, Shimadsu, Toshiba, LMT Medical Systems, Neusoft, Siemens Healthineers, Esaote, Rapid Biomedical, Hallmarq Veterinary, QED (Quality Electrodynamics) and NORAS MRI products) compete in Brazil across the type lines above. The commercially relevant division is 45% of 2025 revenue in 12-32 Channels, where the volume is, against 13.92% growth in More Than 32 Channels, where share moves.

Mexico is sized at USD 27.8 million in 2025, rising to USD 60.2 million by 2034; 1.5% of global revenue and 30% of Latin America. It is reported separately from Brazil across every segmentation axis in the full report.

USD 92.5 million of 2025 revenue is generated in Middle East and Africa, 5% of the global head coil market and reaches USD 200.8 million by 2034. Among the five regions it ranks fifth by revenue in both years.

5.5% of global revenue sits here by 2034, up from the 2025 level, at a pace above the 7.74% global rate, which is what makes this region worth reading separately rather than scaling from the total.

The type mix reported at global level applies here, with 12-32 Channels the largest line at 45% of 2025 revenue and More Than 32 Channels the fastest-growing at 13.92%. Per-axis and per-country detail for Middle East and Africa sits in the full report.

The largest single market in Middle East and Africa is Saudi Arabia, at USD 27.8 million in 2025 and USD 60.2 million in 2034. It accounts for 30% of regional revenue in the base year, the largest single share without dominating the region outright. Regional revenue of USD 92.5 million in 2025 and USD 200.8 million in 2034 sits around it, and it is the country used wherever the full report cuts a figure by geography.

Saudi Arabia buys along the same lines as the market globally; 12-32 Channels first at 45% of 2025 revenue and 40% in 2034, More Than 32 Channels fastest at 13.92% on a share moving from 25% to 42%. Since 30% of Middle East and Africa's revenue is generated here, the regional numbers inherit this market's mix rather than smoothing it out. Revenue by type for Saudi Arabia is reported separately in the full report.

In Saudi Arabia, head coils are regulated by the Saudi Food and Drug Authority under its national medical device framework, which draws heavily on international regulatory approaches and requires listing of the device and its manufacturer before market entry. A supplier must appoint a local authorized representative, classify the coil according to its intended purpose and risk, and demonstrate conformity with recognized international standards through technical documentation and a certified quality management system. Arabic labelling covering intended use, compatibility, and safety warnings is required alongside the original language documentation. Continued market presence depends on maintaining establishment licensing, cooperating with post-market surveillance requests, and reporting adverse events to the authority.

In Saudi Arabia the field is GE, MR Instruments, Philips, Hitachi, Shimadsu, Toshiba, LMT Medical Systems, Neusoft, Siemens Healthineers, Esaote, Rapid Biomedical, Hallmarq Veterinary, QED (Quality Electrodynamics) and NORAS MRI products. Two different problems sit on the same axis: holding 12-32 Channels at 45% of 2025 revenue, and taking More Than 32 Channels while it grows at 13.92%.

1.1% of global revenue is generated in the United Arab Emirates; USD 20.4 million in 2025, reaching USD 44.2 million in 2034, and 22% of Middle East and Africa.

Within Middle East and Africa, South Africa accounts for 18% of regional revenue and 0.9% of the global total, worth USD 16.7 million in 2025 and USD 36.1 million by 2034.

Request this sample to see the full data tables and segment-level detail behind this analysis.

This report assesses the market across every segment, with revenue and a growth rate for each line in each year of the study period. It covers the drivers, trends, opportunities, restraints and challenges shaping growth, the competitive landscape and the companies profiled, and the research methodology behind every estimate. Segmentation is reported by Type, Application, Coil Design, End User, Field Strength, and regional analysis covers North America, Europe, Asia Pacific, Latin America, Middle East and Africa, each broken out by country.